Sonia Pinelo-Molina

Sevilla, AN, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

UGT2B17 as a predictive biomarker of complete pathological response in HER2 + breast cancer.

UGT2B17 as a predictive biomarker of complete pathological response in HER2 + breast cancer.

Journal: Breast cancer (Tokyo, Japan)

Published: November 24, 2025

Lineage plasticity and histological transformation: tumor histology as a spectrum.

Lineage plasticity and histological transformation: tumor histology as a spectrum.

Journal: Cell research

Published: February 12, 2025

Interleukin-11 promotes lung adenocarcinoma tumourigenesis and immune evasion.

Interleukin-11 promotes lung adenocarcinoma tumourigenesis and immune evasion.

Journal: Clinical and translational medicine

Published: December 04, 2024

Small cell lung cancer unveiled: Exploring the untapped resource of circulating tumor cells-derived organoids.

Small cell lung cancer unveiled: Exploring the untapped resource of circulating tumor cells-derived organoids.

Journal: Critical reviews in oncology/hematology

Published: October 01, 2024

Predictive factors for complete pathologic response in luminal breast cancer: impact of ki67 and HER2 low expression.

Predictive factors for complete pathologic response in luminal breast cancer: impact of ki67 and HER2 low expression.

Journal: Therapeutic advances in medical oncology

Published: August 12, 2024

CDC7 inhibition impairs neuroendocrine transformation in lung and prostate tumors through MYC degradation.

CDC7 inhibition impairs neuroendocrine transformation in lung and prostate tumors through MYC degradation.

Journal: Signal transduction and targeted therapy

Published: February 19, 2024

Targeting the Tumor Microenvironment in Breast Cancer: Prognostic and Predictive Significance and Therapeutic Opportunities.

Targeting the Tumor Microenvironment in Breast Cancer: Prognostic and Predictive Significance and Therapeutic Opportunities.

Journal: International journal of molecular sciences

Published: October 25, 2023

Inhibition of HSP90 in Driver Oncogene-Defined Lung Adenocarcinoma Cell Lines: Key Proteins Underpinning Therapeutic Efficacy.

Inhibition of HSP90 in Driver Oncogene-Defined Lung Adenocarcinoma Cell Lines: Key Proteins Underpinning Therapeutic Efficacy.

Journal: International journal of molecular sciences

Published: August 21, 2023

Landscape of tumor and immune system cells-derived exosomes in lung cancer: mediators of antitumor immunity regulation.

Landscape of tumor and immune system cells-derived exosomes in lung cancer: mediators of antitumor immunity regulation.

Journal: Frontiers in immunology

Published: August 18, 2023

Telomere-based risk models for the early diagnosis of lung cancer.

Telomere-based risk models for the early diagnosis of lung cancer.

Journal: Heliyon

Published: June 12, 2023

Abemaciclib, Palbociclib, and Ribociclib in Real-World Data: A Direct Comparison of First-Line Treatment for Endocrine-Receptor-Positive Metastatic Breast Cancer.

Abemaciclib, Palbociclib, and Ribociclib in Real-World Data: A Direct Comparison of First-Line Treatment for Endocrine-Receptor-Positive Metastatic Breast Cancer.

Journal: International journal of molecular sciences

Published: April 04, 2023

Aberrant Methylation of the Imprinted C19MC and MIR371-3 Clusters in Patients with Non-Small Cell Lung Cancer.

Aberrant Methylation of the Imprinted C19MC and MIR371-3 Clusters in Patients with Non-Small Cell Lung Cancer.

Journal: Cancers

Published: February 02, 2023

Showing 1-12 of 54

Last Updated: 09/26/2026